| The Study Group for Infectious Diseases has been created with the goal of conducting research on the management of infections occurring in cancer patients, and therefore mainly on the management of febrile neutropenia. Two large multinational multicentric surveys have been designed by the Study Group.
The first one (survey 1) focused mainly on the identification of prognostic factors for the outcome of the febrile episode with the ultimate goal of selecting, at presentation, patients at low-risk for development of a serious medical complication.
The second one (survey 2) is ongoing and has, as first objective, the modelisation of the time to neutrophil recovery at fever onset.
The Study Group is chaired by Jean Klastersky, founding president of MASCC; the members are coming from a large variety of countries and continents. The daily management (data managing and analyses) of the surveys is taken in charge at Institut Bordet (Data Centre) with the collaboration of participating institutions.
 Go to Survey 1 & 2click here
|
